![Konstantin Poukalov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Konstantin Poukalov
Fondateur chez
ARYA SCIE
Fortune : 2 310 $ au 30/06/2026
Profil
Konstantin Poukalov is the founder of ARYA Sciences Acquisition Corp.
III, founded in 2020, where the title held was Chief Business Officer from 2020 to 2021.
Mr. Poukalov is the founder of LianBio, founded in 2019, holding the title of Executive Chairman since 2019.
Mr. Poukalov is the founder of ARYA Sciences Acquisition Corp.
IV, founded in 2021, holding the title of Chief Business Officer since 2021.
Mr. Poukalov is the founder of ARYA Sciences Acquisition Corp.
V, founded in 2021, holding the title of Chief Business Officer since 2021.
Current jobs include Managing Director & Perceptive Discovery Co-Head at Perceptive Advisors (Private Equity) since 2019, Executive Director at Shanghai Lianbio Development Co., Ltd., Director at Prolaio, Inc., and Director at Vapotherm, Inc. since 2024.
Former jobs include Independent Director at Landos Biopharma, Inc. from 2019 to 2021, Independent Director at Lyra Therapeutics, Inc. from 2020 to 2024, Chief Financial & Accounting Officer, Executive VP at Kadmon Holdings, Inc. from 2014 to 2018, Member at Jefferies LLC from 2009 to 2012, Member at UBS Investment Bank (US) from 2006 to 2009, Chief Financial Officer & Executive Vice President at Kadmon Corp.
LLC, and Chief Business Officer at ARYA Sciences Acquisition Corp.
II.
Education includes undergraduate studies at Stony Brook University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIANBIO 0,02% | 15/02/2024 | 17 082 ( 0,02% ) | 2 310 $ | 30/06/2026 |
Postes actifs de Konstantin Poukalov
| Sociétés | Poste | Début |
|---|---|---|
| ARYA SCIE | Fondateur | 01/01/2021 |
| LIANBIO | Fondateur | 17/07/2019 |
| ARYA SCIENCES ACQUISITION CORP V | Fondateur | 22/02/2021 |
| VAPOTHERM, INC. | Directeur/Membre du Conseil | 20/09/2024 |
Shanghai Lianbio Development Co., Ltd.
 Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures paradigm-shifting medicines to patients | Directeur/Membre du Conseil | - |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Corporate Officer/Principal | 01/03/2019 |
Prolaio, Inc.
 Prolaio, Inc. BiotechnologyHealth Technology Operates as a patient-centered clinical intelligence company dedicated to cardiology research and care ecosystem | Directeur/Membre du Conseil | - |
Anciens postes connus de Konstantin Poukalov
| Sociétés | Poste | Fin |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/12/2024 |
| LANDOS BIOPHARMA, INC. | Directeur/Membre du Conseil | 27/08/2021 |
| ░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Konstantin Poukalov
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Vapotherm, Inc.
 Vapotherm, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets respiratory devices | Health Technology |
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UBS Investment Bank (US)
 UBS Investment Bank (US) Investment Banks/BrokersFinance Provides investment banking services | Finance |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Finance |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
ARYA Sciences Acquisition Corp. II
 ARYA Sciences Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
ARYA Sciences Acquisition Corp. IV
 ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. V
 ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Operates as a blank check company | Finance |
Shanghai Lianbio Development Co., Ltd.
Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures paradigm-shifting medicines to patients | Health Technology |
Prolaio, Inc.
Prolaio, Inc. BiotechnologyHealth Technology Operates as a patient-centered clinical intelligence company dedicated to cardiology research and care ecosystem | Health Technology |
Choisissez Zonebourse 
